Enclomisign is a non-steroidal estrogen receptor antagonist in development for secondary hypogonadism in overweight men wishing to restore normal testicular function. Women who face pregnancy failure due to PCOS and ovulatory dysfunction is often recommended Enclomisign (Enclomiphene) to rule out this condition. Polycystic ovary syndrome is a hormonal disorder that hinders the ovulation process when the ovary releases an egg. As a result, ovaries become inflamed and develop cysts, which further result in irregular menstrual periods. Women who face pregnancy failure due to PCOS and ovulatory dysfunction is often recommended Enclomisign (Enclomiphene) to rule out this condition. It can temporarily correct the ovulation process in women dealing with infertility.